Patent · US Active

Compounds for treating neuropsychiatric conditions

US8674095B2 · kind B2 · utility

2Cited by
2References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2009
Grant dateMar 18, 2014
Priority date
Expiry dateJan 30, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are pyrido[2,3-D]pyrimidin-7(8H)-one compounds and compositions useful as PAK inhibitors. Also provided herein are methods of utilizing these compounds for the treatment of neuropsychiatric conditions. The compounds modulate dendritic spine morphology and/or synaptic function.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.